Construction of a robust, proprietary double-ended sequencing process
$589,904P01FY2005HGNIH
454 Life Sciences Corporation, Branford CT
Investigators
Linked publications, trials & patents
Abstract
Abstract Not Provided.
View original record on NIH RePORTER →